The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
<b>Background/objectives:</b> Mycosis fungoides (MF) is a rare malignancy, with an indolent course in the early stages of the disease. However, due to major molecular and clinical heterogeneity, patients at an advanced stage of the disease have variable responses to treatment and conside...
Saved in:
Main Authors: | Angelica Johansson, Eirini Kalliara, Emma Belfrage, Teodor Alling, Paul Theodor Pyl, Anna Sandström Gerdtsson, Urban Gullberg, Anna Porwit, Kristina Drott, Sara Ek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/186 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
by: Francine Foss, et al.
Published: (2025-12-01) -
Hypopigmented mycosis fungoides: an important differential diagnosis of hypochromias in childhood
by: Maria Fernanda de Almeida Cavalcante Aranha, et al.
Published: (2025-01-01) -
Application of immunohistochemical markers in mycosis fungoides
by: SHAO Kaixin, et al.
Published: (2025-01-01) -
Dermoscopy of Early-Stage Mycosis Fungoides: Comparative Study with Inflammatory Dermatoses
by: Amel Chabbouh, et al.
Published: (2025-01-01) -
Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians
by: Larisa Geskin, et al.
Published: (2024-11-01)